Full List Of Stories
![maersk dl ship shipping china nz new zealand maersk dl ship shipping china nz new zealand](https://img.s3wfg.com/web/img/images_uploaded/9/a/maersk_dl_ship_shipping_china_nz_new_zealand_285x185.jpg)
Maersk returns to Red Sea but Hapag-Lloyd says 'too dangerous'
Shipping giant Maersk on Wednesday said it would operate several dozen container vessels via the Suez Canal and the Red Sea in the coming days and weeks despite recent attacks on vessels by Yemen's Houthi militant group.
Europe midday: Shares rally on US rate cut hopes, China data
European shares rallied at midday on Wednesday on the back of a strong Wall Street session overnight, strong data from China and hopes the US Federal Reserve will start to cut rates earlier in the new year.
Europe close: Shares close higher as US rally continues on rate hopes
European shares closed higher on Wednesday as US shares continued to rally amid hopes the US Federal Reserve will start to cut rates earlier in the new year.
![dl jeremy hunt mp conservative party tory politician commons 3 dl jeremy hunt mp conservative party tory politician commons 3](https://img6.s3wfg.com/web/img/images_uploaded/a/0/dl-jeremy-hunt-mp-conservative-party-tory-politician-commons-3_285x185.jpg)
UK spring Budget set for March 6, fuelling election speculation
Britain's spring budget statement will be delivered on March 6, the Treasury announced on Wednesday, amid suggestions the government may axe inheritance tax in an attempt to narrow a large opinion poll deficit ahead of a General Election which must be called by January 2025.
Europe open: Shares edge ahead on Wall St, China data
European shares crept ahead at the open on Wednesday on the back of a Wall Street and strong data from China.
![dl astrazeneca r dl astrazeneca r](https://img6.s3wfg.com/web/img/images_uploaded/a/0/dl_astrazeneca_rd_285x185.jpg)
AstraZeneca to buy Gracell Technologies for $1.2bn
AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1. 2bn.